Brief: Ligand Pharmaceuticals Says Quarterly Diluted Net Income Per Share $0.02

Ligand Pharmaceuticals Incorporated

07/11/2022 21:35

Nov 7 (Reuters) - Ligand Pharmaceuticals Inc  LGND.O :
    * QTRLY DILUTED NET INCOME PER SHARE $0.02 
    * LIGAND REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
    * EXPECT FY22 TOTAL REVENUE OF $184 MILLION TO $189 MILLION
    * REVENUE FOR THE THIRD QUARTER OF 2022 WAS $66.1 MILLION,
COMPARED WITH $64.8 MILLION FOR THE SAME PERIOD IN 2021
    * Q3 EARNINGS PER SHARE VIEW $0.43, REVENUE VIEW $38.3
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID: 
Further company coverage:  LGND.O 
 ((Reuters.Brief@thomsonreuters.com;))